Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03135444 · ClinicalTrials.gov registry record · NA
PSA TOOL for Prostate Cancer Screening Discussions
A NA study, sponsored by Case Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 95
- Enrollment target
NCT03135444 is a NA study that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 95 participants.
The verdict
NCT03135444, a NA study, has completed, sponsored by Case Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 95 participants
- Enrollment target
Study Summary
The study team created a tool to help identify patients who may benefit from shared decision making in the primary care setting. This tool is a guide to aid in decision making for prostate cancer screening. The team proposes the topics to be discussed in the screening conversation include the risk for developing prostate cancer based upon age, race/ethnicity, family history of prostate cancer, history of previous digital rectal exam, and history of previous prostate specific antigen (PSA) as well as self-reported health status and preferences for treatment. The team now proposes 1) testing this tool first for ease of use in primary care clinics 2) revising this tool based upon feedback from patients and providers, then 3) testing this tool for effectiveness in improving patient knowledge that they have an option to be screened for prostate cancer and of specific factors to be considered in the screening decision.
Interventions
- BEHAVIORAL PSA TOOL
- BEHAVIORAL Revised PSA TOOL
- BEHAVIORAL Informal Interview
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 95 participants |
| Start Date | 2017-05-02 |
| Est. Completion | 2018-04-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03135444
The ClinicalTrials.gov registry entry for NCT03135444 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 95 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which PSA TOOL is the first listed.
NCT03135444 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03135444 about?
NCT03135444 is a clinical study titled "PSA TOOL for Prostate Cancer Screening Discussions". The study team created a tool to help identify patients who may benefit from shared decision making in the primary care setting. This tool is a guide to aid in decision making for prostate cancer screening. The team proposes the topics to be discussed in the screening conversation include the risk f...
What is the current status of trial NCT03135444?
This trial is currently completed. It is a NA study. The enrollment target is 95 participants. The study started on 2017-05-02. Estimated completion is 2018-04-23.
What interventions are being tested in trial NCT03135444?
The interventions under investigation include: PSA TOOL (BEHAVIORAL), Revised PSA TOOL (BEHAVIORAL), Informal Interview (BEHAVIORAL).
Who is sponsoring clinical trial NCT03135444?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.